Reprise Biomedical
VerifiedReprise Biomedical | Perfusion Decellularization Technology. Learn more
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$65m (Public information from Nov 2023)
Plymouth Minnesota (HQ)
Authorizing premium user...